首页 工具
登录
购物车

搜索结果

Search Results for " ck-1-in-1 "

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T5393 CK1-IN-1

PUN51207

p38 MAPK; Casein Kinase MAPK; Metabolism; Stem Cells
CK1-IN-1 (PUN51207) 是一种酪蛋白激酶 1 抑制剂,对 CK1δ、CK1ε和p38σ MAPK 的IC50值为 15 nM、16 nM 和73 nM。
T10827 CK2/ERK8-IN-1

TMCB

Apoptosis; ERK; Casein Kinase; Pim; DYRK Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; JAK/STAT signaling; MAPK; Metabolism; Stem Cells; Tyrosine Kinase/Adaptors
CK2/ERK8-IN-1 (TMCB) 是一种酪蛋白激酶 2 (CK2) (Ki 为 0.25 µM) 和 ERK8 (MAPK15, ERK7) 的双重抑制剂,IC50 均为 0.50 μM。CK2/ERK8-IN-1 也与 PIM1,HIPK2 和 DYRK1A 结合,Ki 值分别为 8.65 µM,15.25 µM 和 11.9 µM。
TQ0255 Olafertinib

CK-101,EGFR-IN-3,RX-518

EGFR Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors
Olafertinib (RX-518) 是新型突变选择性、不可逆、可口服的EGFR 酪氨酸酶抑制剂,可克服 NSCLC 中 T790M 介导的耐药性。
T10828 CK2/PIM1-IN-1

Others Others
CK2/PIM1-IN-1 is an inhibitor of CK2 and PIM1 (IC50s: 3.787 μM and 4.327 μM). It is developed for the research of proliferative disorders such as cancer, as well as other kinase-associated conditions.
T30953 CK 17

CK-17,CK17

CK-17 is an interleukin-1 antagonist and an IL-1 blocker, which inhibits fibroblast proliferation in a concentration-dependent manner.
T77151 Cosibelimab

Cosibelimab(CK-301; TG-1501)是一种高亲和力、全人源 PD-L1阻断单克隆抗体,可结合 PD-L1并阻断其与 PD-1的相互作用。Cosibelimab 具有功能性 Fc 结构域,能够诱导 ADCC 和补体依赖性细胞毒性 (CDC) 介导的PD-L1+细胞系杀伤,包括淋巴瘤细胞。

化合物

CK1-IN-1
Cat.No: T5393
Synonym: PUN51207
Target: p38 MAPK, Casein Kinase
CK2/ERK8-IN-1
Cat.No: T10827
Synonym: TMCB
Target: Apoptosis, ERK, Casein Kinase, Pim, DYRK
Olafertinib
Cat.No: TQ0255
Synonym: CK-101,EGFR-IN-3,RX-518
Target: EGFR
CK2/PIM1-IN-1
Cat.No: T10828
Synonym:
Target: Others
CK 17
Cat.No: T30953
Synonym: CK-17,CK17
Target:
Cosibelimab
Cat.No: T77151
Synonym:
Target:
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼